Image

HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)

HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)

Non Recruiting
20-65 years
All
Phase N/A

Powered by AI

Overview

The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Post Acute Covid Syndrome (PACS).

The main questions it aims to answer are:

Can the current HOBSCOTCH program be adapted for people with PACS?

Will people with PACS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program?

Participants will be asked to:

  • attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PACS sessions with a one-on-one certified HOBSCOTCH-PACS coach
  • complete a brief clinical questionnaire about their diagnosis of PACS
  • complete seven questionnaires before and after the HOBSCOTCH-PACS sessions about their quality of life, memory and thinking processes (objective and subjective cognition), about their physical and mental health and about autonomic symptoms associated with their diagnosis of PACS
  • keep a short daily diary (using a smart phone app or on paper) about their PACS symptoms and use of the self-management strategies taught in the HOBSCOTCH-PACS program
  • complete two brief surveys to assess satisfaction with their experience after the entire HOBSCOTCH-PACS program

Eligibility

Inclusion Criteria:

  • Literate, English-speaking with grade 12 or equivalent in education
  • Self-reported diagnosis of PACS
  • Self-reported cognitive/memory difficulties
  • Telephone and internet access

Exclusion Criteria:

  • Cognitive dysfunction that precludes participation in giving informed consent
  • Significant visual impairment precluding reading or writing
  • No reliable telephone or internet access
  • Neurodegenerative illness (i.e. dementia)
  • Acute psychiatric disease

Study details
    Post Acute COVID 19 Syndrome
    Memory Impairment
    Memory Dysfunction
    Cognitive Dysfunction

NCT06391489

Dartmouth-Hitchcock Medical Center

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.